Crystallization of human complement component C5

被引:3
|
作者
Discipio, RG
Jenner, L
Thirup, S
Sottrup-Jensen, L
Nyborg, J
Stura, E
机构
[1] La Jolla Inst Expt Med, La Jolla, CA 92037 USA
[2] Univ Aarhus, Dept Mol & Struct Biol, DK-8000 Aarhus C, Denmark
[3] CEA Saclay, Dept Prot Engn, F-91191 Gif Sur Yvette, France
关键词
D O I
10.1107/S0907444997015011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human complement component C5 has been crystallized using a low-salt batch technique. The crystals are large hexagonal bipyramids often larger than 1.5 mm. Although these crystals were grown in low salt (0.1 M NaCl), they are remarkably stable for at least 2 months at 281 K and they are not dissolved in aqueous buffers containing up to 2 M sodium chloride. The space group is P3(1)21 or P3(2)21, and the cell parameters were determined to be a = 144.9, b = 144.9, c = 243.1 Angstrom; alpha = 90 degrees, beta = 90, gamma = 120 degrees. At room temperature and cryo-temperatures the crystals diffract at best to 6 Angstrom using rotating-anode X-ray sources. Using synchrotron radiation with cryoprotection using 40%(nu/nu)(-) PEG 400 the resolution limit can be extended to 3.3 Angstrom. In both cases the crystals show significant anisotropy, with relatively weaker reflections at higher resolution in the a*b* plane.
引用
收藏
页码:643 / 646
页数:4
相关论文
共 50 条
  • [41] ACTIVATION OF THE 5TH COMPONENT OF HUMAN-COMPLEMENT, C5, WITHOUT CLEAVAGE, BY METHIONINE OXIDIZING-AGENTS
    VOGT, W
    ZIMMERMANN, B
    HESSE, D
    NOLTE, R
    MOLECULAR IMMUNOLOGY, 1992, 29 (02) : 251 - 256
  • [42] THE LOW C5 CONVERTASE ACTIVITY OF THE C4A6 ALLOTYPE OF HUMAN-COMPLEMENT COMPONENT C-4
    KINOSHITA, T
    DODDS, AW
    LAW, SKA
    INOUE, K
    BIOCHEMICAL JOURNAL, 1989, 261 (03) : 743 - 748
  • [43] Transcriptomic 'portraits' of transient inflammatory arthritis in C5 complement component deficient mice
    Adarichev, V.
    Brucker, J.
    Lyons, E. T.
    Shekhani, M. T.
    Forde, T. S.
    IMMUNOLOGY, 2012, 137 : 198 - 198
  • [44] Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5
    Durigutto, Paolo
    Macor, Paolo
    Ziller, Federica
    De Maso, Luca
    Fischetti, Fabio
    Marzari, Roberto
    Sblattero, Daniele
    Tedesco, Francesco
    PLOS ONE, 2013, 8 (03):
  • [45] Inhibition of complement component C5 protects porcine chondrocytes from xenogeneic rejection
    Sommaggio, R.
    Perez-Cruz, M.
    Brokaw, J. L.
    Manez, R.
    Costa, C.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 (12) : 1958 - 1967
  • [46] Role of murine complement component C5 during in vivo infection by pathogenic leptospires
    de Castro, Iris Arantes
    Bavia, Lorena
    Amano, Mariane Tami
    Goncalves da Silva, Ana Maria
    Morais, Zenaide Maria
    Vasconcellos, Silvio Arruda
    de Britto, Thales
    Isaac, Lourdes
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 237 - 237
  • [47] A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration
    Mastellos, D
    Papadimitriou, JC
    Franchini, S
    Tsonis, PA
    Lambris, JD
    JOURNAL OF IMMUNOLOGY, 2001, 166 (04): : 2479 - 2486
  • [48] COMPLEMENT-INDEPENDENT ACTIVATION OF THE FIFTH COMPONENT (C5) OF HUMAN-COMPLEMENT - LIMITED TRYPSIN DIGESTION RESULTING IN THE EXPRESSION OF BIOLOGIC ACTIVITY
    WETSEL, RA
    KOLB, WP
    JOURNAL OF IMMUNOLOGY, 1982, 128 (05): : 2209 - 2216
  • [49] FUNCTIONAL ACTIVITY OF FIFTH COMPONENT OF COMPLEMENT (C5) IN HUMAN, ANIMAL, PROPRIETARY AND SOY MILKS - THERAPEUTIC AND BIOLOGIC IMPLICATIONS
    MILLER, ME
    PEDIATRIC RESEARCH, 1974, 8 (04) : 415 - 415
  • [50] THE 5TH COMPONENT OF COMPLEMENT (C5) IN THE MOUSE ANALYSIS OF THE MOLECULAR-BASIS FOR DEFICIENCY
    STRUNK, RC
    WHEAT, WH
    WETSEL, R
    FALUS, A
    RAMADORI, G
    TACK, BJ
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 1102 - 1102